LENZ Therapeutics (LENZ) EBT (2020 - 2026)
LENZ Therapeutics (LENZ) reported EBT of -$41.5 million for Q1 2026, down 184.03% year-over-year from $49.4 million in Q1 2025, and down 15.59% quarter-over-quarter from -$35.9 million in Q4 2025.
LENZ Therapeutics (LENZ) EBT (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of EBT data on file, last reported at -$41.5 million in Q1 2026.
- EBT for Q1 2026 came in at -$41.5 million, down 184.03% year-over-year; the trailing twelve-month figure through Mar 2026 was -$108.5 million (down 127.32% YoY), and the FY2025 annual result was -$81.6 million, down 64.01% from the prior year.
- EBT fell to -$41.5 million in Q1 2026 per LENZ's latest filing, from -$35.9 million in the prior quarter.
- Over five years, EBT peaked at -$10.2 million in Q3 2024 and troughed at -$41.5 million in Q1 2026.
- A 5-year average of -$20.4 million and a median of -$16.7 million in 2025 frame the typical range for EBT.
- The sharpest annual moves came in 2023 and 2026: EBT surged 51.4% in 2023, then slumped 184.03% in 2026.
- A 5-year view of EBT shows it stood at -$26.8 million in 2022, then increased by 9.77% to -$24.1 million in 2023, then soared by 47.59% to -$12.7 million in 2024, then slumped by 183.72% to -$35.9 million in 2025, then fell by 15.59% to -$41.5 million in 2026.
- Business Quant data shows LENZ's EBT at -$41.5 million in Q1 2026, -$35.9 million in Q4 2025, and -$16.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.18 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.31 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.50 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.25 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -56.48 Mn |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | -41.49 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.49 Mn |
| Dec 31, 2025 | -35.89 Mn |
| Sep 30, 2025 | -16.70 Mn |
| Jun 30, 2025 | -14.41 Mn |
| Mar 31, 2025 | -14.61 Mn |
| Dec 31, 2024 | -12.65 Mn |
| Sep 30, 2024 | -10.22 Mn |
| Jun 30, 2024 | -10.25 Mn |
| Mar 31, 2024 | -15.30 Mn |
| Dec 31, 2023 | -24.14 Mn |
| Sep 30, 2023 | -18.78 Mn |
| Jun 30, 2023 | -14.71 Mn |
| Mar 31, 2023 | -12.62 Mn |
| Dec 31, 2022 | -26.75 Mn |
| Sep 30, 2022 | -26.15 Mn |
| Jun 30, 2022 | -26.78 Mn |
| Mar 31, 2022 | -25.96 Mn |
| Dec 31, 2021 | -18.94 Mn |
| Sep 30, 2021 | -14.60 Mn |
| Jun 30, 2021 | -17.53 Mn |